[Extracorporeal shockwave therapy in the treatment of chronic insertional Achilles tendinopathy]

Orthopade. 2005 Jun;34(6):571-8. doi: 10.1007/s00132-005-0806-9.
[Article in German]


Purpose: The purpose of this study was to determine the efficacy of extracorporeal shock wave therapy (ESWT) for the treatment of adults with chronic insertional Achilles tendinopathy.

Methods: 68 patients with chronic insertional Achilles tendinopathy were enrolled in this study. A total of 35 patients were treated with a single dose of ESWT (3000 shocks of 0.20 mJ/mm(2), ESWT group), while 33 patients were treated with traditional non-operative measures (control group).

Results: At 3 months post treatment, the mean VAS for the control and ESWT groups were 2.9 and 7.2 respectively. Using the Roles and Maudsley scale, 39% of the control patients and 51% of the ESWT patients were assigned an excellent or good result.

Conclusions: ESWT as applied is a safe and effective treatment for chronic insertional Achilles tendinopathy.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Achilles Tendon / injuries*
  • Adult
  • Aged
  • Chronic Disease
  • Cumulative Trauma Disorders / therapy*
  • Female
  • Humans
  • Lithotripsy / methods*
  • Male
  • Middle Aged
  • Tendinopathy / therapy*
  • Tendon Injuries / therapy*
  • Treatment Outcome